Pereiti prie pagrindinio turinio

Adresas

Panerių g. 246
48454 Kaunas
Lietuva

Darbo laikas

  • Pi – Pe
    9 :00 – 17 00
  • Še  
    Nedirbame    
  • Se
    Nedirbame   
Dog DNA testing illustration

Degenerative Myelopathy Exon 2 (DM Exon 2) (External Patent Lab)

Kodas: H806

157,30 €

Mėginio duomenys

Vienas tyrimas – vienas mėginys. Gyvūno ir savininko duomenys neprivalomi.

Ieškokite pagal mūsų ar laboratorijos numerį. Nerastas numeris išsaugomas kaip ankstesnis / išorinis numeris. Naujo fizinio mėginio nereikia.
Įdėjimo į krepšelį mygtukas pasirodys po to, kai aukščiau pasirinksite reikšmę

Short description

Canine Degenerative Myelopathy (DM) is an incurable progressive neurodegenerative disease of the spinal cord.

General information

Canine Degenerative Myelopathy (DM) is an incurable progressive neurodegenerative disease of the spinal cord. Neurodegenerative diseases are characterised by progressive loss of neurons in the central nervous system (CNS) which leads to deficiencies in function. In the case of DM, the affected region is the spinal cord, which results in ataxia (a loss of coordination). DM is similar in many ways to Amyotrophic Lateral Sclerosis (ALS) in humans.

This variant of the disease, sometimes designated as SOD1A or as Degenerative Myelopathy Exon 2, occurs in many different breeds. It is probely caused by an autosomal recessive mutation with incomplete penetrance to the gene SOD1. The variant is found in many breeds, but the disease is rarely diagnosed in breeds or in mixed-breed dogs other than those mentioned for this test.

For DM in Pembroke Welsh Corgis there are also multiple Degenerative Myelopathy Risk Modifiers (DMRM) descibed in literature. These SP110 mutations are available for testing in a different package.

Specifications

Breeds

American Water Spaniel, Borzoi, Glen of Imaal Terrier, Poodle (Standard), Schnauzer (Giant), Schnauzer (Miniature), Wire Fox Terrier, Airedale Terrier, Komondor, American Eskimo dog, Australian Shepherd, Bernese Mountain dog, Bloodhound, Boston Terrier, Boxer, Boykin Spaniel, Cardigan Welsh Corgi, Cavalier King Charles Spaniel, Chesapeake Bay Retriever, English Springer Spaniel, French Bulldog, German Shepherd, Golden Retriever, Jack Russell Terrier, Kerry Blue Terrier, Labrador Retriever, Nova Scotia Duck Tolling Retriever, Pembroke Welsh Corgi, Pug, Rhodesian Ridgeback, Scottish Deerhound, Shetland Sheepdog, Siberian Husky, Soft Coated Wheaten Terrier

Gene

SOD1

Chromosome

31

Mutation

c.118G>A

Organ

Nervous System

Specimen

Swab, Blood EDTA, Blood Heparin, Semen, Tissue

Mode of Inheritance

Autosomal Recessive with Incomplete Penetrance

Also known as

DM

Clinical features

The mutation for DM is present in almost all dog breeds, but in many breeds, it does not cause clinical symptoms. Most dogs that might be affected are at least 5 years of age or older, at the onset of the clinical signs which include reduced strength in the hind legs, incontinence, hyporeflexia, spasticity and ataxia of the pelvic with progression over time to complete paralysis.

Additional information

This test is performed by an external laboratory. CombiBreed takes care of the mediation between you as a customer and the external laboratory. In this case, CombiBreed cannot be held liable for the behaviour of the client and/or contractor.

References

Pubmed ID: 19188595

Year published: 2009

Omia ID: 263

Omia variant ID:

Turnaround information

  • 25 working days
  • This test is performed by an external laboratory.
  • CombiBreed takes care of the mediation between you as a customer and the external laboratory.